Like M-CSF inhibition, IL-34 neutralization alone (1 ug/mL of anti-IL-34) was unable to completely prevent M-MDSC differentiation from glioma-conditioned media (Figure 4A, Supplemental Figure S2A). The gene discussed is CSF1; the disease is central nervous system cancer.